rs4977433

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_004529.4(MLLT3):c.193+35421C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene MLLT3 is a known oncogene (CancerMine: 1 TSG, 29 oncogene, 280 driver citations). The gene MLLT3 is a cancer driver gene (CancerMine: 1 TSG, 29 oncogene, 280 driver citations). The variant allele was found at a cumulative frequency of 0.405 (AC=61,473) in the gnomAD database across 151,932 control chromosomes, including 13,120 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.489. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 13120 hom., cov: 31)

Consequence

MLLT3
NM_004529.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.715

Publications

3 publications found
Variant links:
Genes affected
MLLT3 (HGNC:7136): (MLLT3 super elongation complex subunit) Enables several functions, including chromatin binding activity; histone H3 reader activity; and histone binding activity. Involved in several processes, including hematopoietic stem cell differentiation; positive regulation of DNA-templated transcription; and regulation of stem cell division. Acts upstream of or within negative regulation of canonical Wnt signaling pathway and positive regulation of Wnt signaling pathway, planar cell polarity pathway. Located in nucleoplasm. Part of transcription elongation factor complex. [provided by Alliance of Genome Resources, Jun 2026]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004529.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.489 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_004529.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MLLT3 NM_004529.4
MANE Select
HGVSc / HGVSpc.193+35421C>T
Exon rankIntron 2 of 10
intron
Prot: NP_004520.2UniProt: A0A0S2Z448P42568-1
MLLT3 NM_001286691.2
HGVSc / HGVSpc.184+35421C>T
Exon rankIntron 2 of 10
intron
Prot: NP_001273620.1UniProt: P42568-2

Ensembl Transcripts

MLLT3 ENST00000380338.9
TSL:1MANE Select
HGVSc / HGVSpc.193+35421C>T
Exon rankIntron 2 of 10
intron
Prot: ENSP00000369695.4UniProt: P42568-1
MLLT3 ENST00000630269.2
TSL:2
HGVSc / HGVSpc.184+35421C>T
Exon rankIntron 2 of 10
intron
Prot: ENSP00000485996.1UniProt: P42568-2
MLLT3 ENST00000475957.1
TSL:2
HGVSc / HGVSpn.377+35421C>T
Exon rankIntron 2 of 4
intron
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.405
AC:61442
Hom:13119
AN:151814
Cov:31
GnomAD4 genome
AF: 0.405
AC:61473
Hom:13120
AN:151932
Cov:31
TOPMed (Bravo)
AF: 0.399
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.441
AC:37552
Hom:8928
AN:85114
Local & regional cohorts 9 sources
ABraOM SABE-WGS-1171
AF: 0.431
AC:996
Hom:218
AN:2310
ChinaMAP Phase 1
AF: 0.240
Denmark Genome
AF: 0.427
AC:128
AN:300
Korea4K (4,157 Koreans)
AF: 0.193
AC:1397
AN:7228
Qatari Genome
AF: 0.489
AC:86
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.203
AC:24896
Hom:2476
AN:122660
Turkish Variome
AF: 0.449
AC:693
Hom:147
AN:1544
UK10K
AF: 0.488
AC:3687
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.245
AC:2196
Hom:259
AN:8960
Showing 13 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign4.6
BayesDel_noAF
Benign-0.94
CADD
Benign1.0
DANN
Benign0.53
GPN-Star LLR
N/A0.083
GPN-Star score
N/A-0.083
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-0.71
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.